Cost of weight loss drug Mounjaro may rise significantly
The weekly injection works by making you feel full so you eat less, and can help people lose 20% of their body weight.Currently there are thought to be around 1.5 million people on weight loss drugs in the UK with more than half of them on Mounjaro. Estimates suggest nine in 10 pay for these drugs privately, buying from online services and high street pharmacies.Eli Lilly said the drug had been sold in the UK at a price that was "significantly below" that charged in other European countries.
Trump threat
It comes after US President Donald Trump complained about the high cost of drugs in the US.He has threatened the pharmaceutical industry with a "most favoured nation" drug pricing proposal to peg US prices to those abroad.Eli Lilly said it agreed with the objective expressed by President Trump that costs should be shared more fairly – although a "most favoured nation" approach was not the right answer.Research suggests prices in the US can be three times higher than in other rich nations.In a statement, Eli Lilly said: "The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited availability."At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability."With changes in the environment and new clinical evidence supporting the value of Mounjaro, we are now aligning the list price more consistently to ensure fair global contributions to the cost of innovation."Dr Leyla Hannbeck, head of the Independent Pharmacies Association, said she was "shocked and very disappointed" by the price rise."This is a real blow to patients, at a time when more and more people worried about their weight are turning to jabs. "It is vital that patients who are already taking Mounjaro talk to their local pharmacy before they take any action."Those patients considering weight-loss jabs should also not be put off as Mounjaro is not the only option - local pharmacies are best placed to offer vital advice about the range of treatments available."She said it was important other weight loss drug manufacturers hold their nerve and their prices - alongside Mourjaro Novo Nordisk drug Wegovy is widely used in the UK."The British market for weight-loss jabs will is only set to grow, but it will only achieve that growth if treatment remains affordable to the average patient."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
28 minutes ago
- Daily Mail
Study pinpoints how long it takes to regain weight after stopping weight loss jabs - and it's quicker than you think
Blockbuster weight loss jabs relied on by millions not be the quick fix many believe them to be, as users pile on the pounds within just eight weeks of stopping treatment, experts have warned. More than a million people in the UK are now injecting themselves weekly with drugs such as Mounjaro and Wegovy—bought online or through private clinics—lured by promises of rapid results. Known collectively as GLP-1s, the weekly injections can see users lose up to a fifth of their body weight in as little as a year, upending the obesity treatment playbook. But now experts in metabolic medicine, from Peking University People's Hospital, Beijing, have warned that the results are likely to be short-lived if patients do not maintain a healthy lifestyle after coming off the jabs. Even those taking newer, more powerful jabs like Mounjaro were found to regain the weight once treatment was stopped. The researchers, led by Professors Xiaoling Cai and Lingong Ji, found that even those on trizeparide—the so-called 'King Kong' of weight loss jabs, regained almost half the weight they had previously lost after coming off the drug and switching to a placebo. Whilst the study, published in the journal BMC Medicine, didn't explain exactly why people pile the weight back on so fast, the researchers speculated it could be due to a phenomenon known as 'weight cycling.' This refers to the process of regaining weight after stopping treatment, and can be due to a number of factors. One potential reason for rapid weight gain after coming off the jabs could be due to hormonal changes in the gut. According to the researchers, previous studies with very low energy diets show that weight loss induces adverse hormonal changes in the gut that potentially affect weight regain after treatment. 'This adverse hormonal change in the gut causes an increase in hunger levels and urge to eat, which promotes weight regain,' Prof Cai explained. Other experts, such as Professor Susan Jebb, who was not involved in the study, have speculated the post-treatment weight gain could simply be because diets are hard. No self restraint is required when taking the drugs, so people don't have effective 'behavioural strategies in place' when they stop taking them. The injections trigger weight loss by mimicking the actions of a hormone released in the gut after eating called GLP-1. As well as signalling to the pancreas to make more insulin, this hormone feeds back to the brain, stopping users from overeating. The findings could raise issues for both the Government, which plans to roll out a new £85million weight loss jab trial involving tens of thousands of people offered the drug, and manufacturers such as Eli Lily who announced last week they are increasing the price of their products in the UK. Despite many being eager to take the drugs, the revolutionary jabs are not without side effects, and as such currently only patients with a body mass index (BMI) over 30 and at least one weight-related health problem can qualify for treatment. UK law forbids the sale of drugs such as Wegovy without a prescription from a medical professional. Common side-effects include nausea, constipation and diarrhoea after taking the medication and many users have spoken out about struggling to keep the weight off after stopping the medication. Some doctors have also warned they are seeing patients with serious, life-threatening complications including seizures, bowel obstructions and inflammation of the pancreas, known as pancreatitis. Healthcare watchdog NICE currently advises that users should not be on the injections for more than two years. Tam Fry, chairman of the National Obesity Forum, added: 'It shouldn't surprise anyone if people regain weight having used GLP-1 drugs without seriously attempting to improve their lifestyle. 'Using GLP1-s is not the quick fix which many users believe it to be.'
BBC News
an hour ago
- BBC News
'Chemo wrecked my teeth, I can't afford treatment'
A woman who says her teeth were destroyed by cancer treatment says dental care in the UK "feels like we're going back to Victorian times".Faye Woodley, who is unable to work because of chronic illness, said she was unable to afford the required treatment to fix her teeth, which would cost thousands of pounds at her said she had "no confidence" in planned NHS dentistry reforms and the current situation felt like a step back in time when "only the rich were well and had good teeth, whereas everyone else suffered".The government's newly-published 10-year health plan said a new dental contract would be at the heart of a "transformed" NHS system by 2035. As a result of her chemotherapy for breast cancer, Ms Woodley said her front teeth were chipped and had holes in and she had lost 10 one molar she had left had no chewing surface, she said, meaning she could only eat soft Woodley, from Chippenham in Wiltshire, gave up work 10 years ago because of health says her teeth problems have left her in pain and she is unable to pay for private treatment as her condition worsens. 'Sleepless nights' "I'm on benefits, I struggle to survive month on month as it is, without having to find nearly £100 for a check up. "I'm going to be looking at thousands and I don't have that money to be able to get my teeth looked after," she Woodley was registered as an NHS patient at Hathaway Dental Practice in Chippenham before it decided to go private last year, and said she could not find another dentist which would offer her NHS Garber, practice director at Hathaway Dental Practice, said the decision to only offer private care to adults was "not easy", and had been made after a struggle to recruit NHS dentists and "sleepless nights". "We lost four NHS dentists within a short space of time who wanted to go to private practices elsewhere," he said."We advertised for eight or nine months to get replacements for NHS dentists and didn't have a single applicant." "It was a case of either doing that [becoming private] or probably going out of business," he Department for Health and Social Care said it had rolled out 700,000 urgent and emergency added its reforms would "bring in measures to make sure NHS-trained dentists work in the NHS for a minimum period".A government consultation with the public about the planned reforms ends on Tuesday.
Telegraph
an hour ago
- Telegraph
High street diagnostic centres opening at evenings and weekends
The NHS delivered more than 1.6 million more tests and scans from July 2024 to June 2025 and there were 218,463 people who had cancer ruled out or diagnosed within 28 days, the Department of Health said. Improved performance on the faster diagnosis standard means that nearly 97,000 more people had cancer diagnosed or ruled out within 28 days between July 2024 and June 2025, compared to the same period last year. At Oldham CDC in Greater Manchester, extended opening hours have cut lung cancer diagnosis times from 42 days to just 18.8 days, while Queen Victoria Hospital CDC in East Grinstead, West Sussex, is recording five times more respiratory patient interactions per session, with 92 per cent avoiding the need for hospital outpatient appointments. Patients can be referred to CDCs through their GP or hospital-based clinical teams. Mr Streeting said the Government's 10-year health plan is 'revolutionising how healthcare works' and the measures are helping to bring care closer to the community. Prof Meghana Pandit, NHS England national medical director, said: 'We know people are living incredibly busy lives and it's vital NHS care reflects that. 'The services provided by community diagnostics centres enable people to receive the all-clear or a diagnosis at a time and location that suits them, whether before a school drop off or after a work shift, and extending their opening hours means more people are being seen more quickly.' CDCs can provide a range of tests including MRI and CT scans, echocardiography and phlebotomy services. Wayne Rowlands, who visited the Norfolk and Norwich University Hospital Community Diagnostic Centre for an emergency CT scan, described it as a 'pleasant experience' in a setting that was 'very bright and not at all like a hospital'. The Government's Plan for Change is backed by more than £6bn of additional capital investment to improve capacity for elective, diagnostic, and urgent care services over five years, with more than £600m capital funding committed for 2025-26 to transform diagnostic services. This includes funding up to five additional CDCs in 2025-26 and extending opening hours for all CDCs at evenings and at weekends. Laura Challinor, of the Blood Cancer UK charity, welcomed the move but said more must be done to tackle regional variation and speed up testing. She said: 'It's imperative that everyone affected by blood cancer can readily access the diagnostic tests and appointments they need. 'With blood cancer being the UK's third biggest cancer killer and survival lagging behind countries of similar wealth and health, doing all we can to turn that tide is critical.'
